In a progression no less dramatic than the blockade caused by a new coronavirus, Russia claimed to be the first country to have a Covid-19 vaccine.
And none other than the Russian president’s daughter reportedly won the vaccine, to foreign media, mentioning Vladimir Putin.
“I know it works effectively, the bureaucracy has strong immunity, and I repeat, it has passed all the mandatory controls,” Putin said in a Reuters report.
The “Sputnik V” vaccine, as it is called, evolved through the Gamaleya Institute in Moscow and received regulatory approvals within two months of human clinical trials. It is reported that the preventive drug will be used for mass vaccination, even if complex trials are being carried out.
The global clinical network has been stifled in its reaction to the Russian vaccine, as the public has little data on it. It is not a component of the global fitness organization’s vaccine landscape.
The Russian vaccine comes at a time when corporations and governments around the world are accelerating and production efforts are “at risk” to have a Covid-19 vaccine for human use as soon as possible.
Vaccine applicants from the mix from Oxford University-AstraZeneca UK, Modern Inc from the United States and Sinovac from China are only the first. And these candidate vaccines are in the final stages of human trials, involving about 30,000 people, the milestones of their studies are published and undergo clinical review.
Vaccine expert Vipin M Vashishtha says it takes at least six months to perceive the protection and efficacy of the Russian vaccine.
“Little is known about the coverage of the antibodies it supplies and for how long. Is it a single-dose or double-dose vaccine? Is it a vector vaccine, etc.,” says Vashishtha, former head of the Indian Academy of Pediatrics (IAP) vaccination committee.
“It’s a specific virus and can even cause a frame immune reaction to degrees that can be harmful,” he warned.
“Cautiously optimistic” about the vaccine, Shashank Joshi, a member of Maharashtra’s Covid Working Group, said Russia had made progress in the race. It remains to be known whether the vaccine is safe and effective for a long time.
“In Covid’s picture, many things have been unpredictable and accelerated,” he says, answering questions about the fact that the Russian vaccine had shortened protocols. “We are not clear because there is no knowledge published in English,” he says, adding, however, that the flu shots taken each year evolve in six weeks.
Alok Roy, chairman of FICCI’s fitness committee and chairman of the medical group Medica, says the news is smart “because it shows the virus can be broken.” In the darkness of the crown, someone lit a match.
To those who criticize the vaccine and its accelerated timing, he replies: “We knew little about coronavirus when it appeared, but we learned on the fly. Similarly, the vaccine will also evolve. Fewer people will die from a vaccine than from the virus. »
Existing users, log in here
Access Hindu Businessline content on desktops, tablets, and mobile devices.
Get a diverse set of insights from our experts in portfolio, banking, economics, environment, and more.
Discover an ad-free cleaner with faster charging times.
Customize your personal tastes and get personalized advice on your interest.
Existing users, log in here
More